Litcius/Paper detail

OA01.04 Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results

Stephen V. Liu, Rafał Dziadziuszko, Shunichi Sugawara, Steven Kao, Maximilian J. Hochmair, Florian Huemer, Gilberto de Castro, Libor Havel, R.B. Caro, G Losonczy, J.-S. Lee, D. Kowalski, Zoran Andrić, Raffaele Califano, Andrea Veatch, Gregory J. Gerstner, Marta Batus, S. Morris, Manika Kaul, M. Siddiqui, H. Li, W. Zhang, Barzin Y. Nabet, Martin Reck

2023Journal of Thoracic Oncology36 citationsDOIOpen Access PDF

Topics & Concepts

AtezolizumabMedicineCarboplatinEtoposideInternal medicinePlaceboOncologyChemotherapyImmunotherapyCisplatinCancerPembrolizumabPathologyAlternative medicineLung Cancer Research StudiesPancreatic and Hepatic Oncology ResearchNeutropenia and Cancer Infections
OA01.04 Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results | Litcius